US Stocks
/
Belite Bio, Inc Share Price

Belite Bio, Inc Share Price

NASDAQ: BLTE
$152.32
-$3.63 (-2.33%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Belite Bio, Inc Stock Performance

Open
$151.91
Prev. Close
$155.95
Circuit Range
N/A
Day Range
$151.02 - $153.59
Year Range
$77.91 - $199.70
Volume
12,542
Average Traded
$151.70

Belite Bio, Inc Share Price Today

As of 9 October 2026, Belite Bio, Inc's share price is $152.32. The stock opened at $151.91, compared to its previous close of $155.95. During today's trading session, Belite Bio, Inc's share price traded between $151.02 and $153.59, with an average price of $152.31. Over the past 52 weeks, the stock has recorded a high of $199.70 and a low of $77.91. In terms of performance, Belite Bio, Inc's share price has declined by 4.33% over the last six months and is up 44.23% on a year-on-year basis.

Belite Bio, Inc Share Price Chart

$151.02$153.59
L
Show Current Price
H

Belite Bio, Inc Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Belite Bio, Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.65-$31.63-$36.14-$77.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-150.04%-14.26%-114.75%

About Belite Bio, Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Belite Bio, Inc Historical Returns

MonthOpenCloseChange %
Oct 2026
$169.83
$152.34
-10.82%
Sep 2026
$154.37
$170.82
+8.74%
Aug 2026
$155.00
$157.09
-1.11%
Jul 2026
$155.56
$158.86
+3.22%
Jun 2026
$136.70
$153.90
+6.75%
May 2026
$157.75
$144.16
-9.46%
Apr 2026
$164.25
$159.22
-0.15%
Mar 2026
$178.00
$159.46
-16.43%
Feb 2026
$169.31
$190.80
+13.07%
Jan 2026
$160.00
$168.74
+5.83%
Dec 2025
$154.00
$159.44
+15.84%
Nov 2025
$114.00
$137.64
+30.33%

BLTE Share Price FAQs

What is Belite Bio, Inc share price today?

chevron-up
Belite Bio, Inc share price today is $152.32 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Belite Bio, Inc stock?

chevron-up
The 52 week high of Belite Bio, Inc stock is $199.70, while the 52 week low is $77.91 as of 9 Oct '26.

What is the 5 year returns of BLTE?

chevron-up
The 5 year returns of BLTE is 1350.67% as on 9 Oct '26.

What is the high & low stock price of BLTE today?

chevron-up
BLTE stock price hit a high of $153.59 and low of $151.02 as of 9 Oct '26.

Can I buy BLTE shares in India?

chevron-up
Yes. You can buy BLTE in India by opening an international trading account.